Supporting Yellow Fever Vaccine Manufacturers Essential To Preventing Widespread Outbreaks

Huffington Post: The Fight Against Yellow Fever Must Go On
Orin Levine, director of vaccine delivery at the Bill & Melinda Gates Foundation

“…The world is facing a supply shortage of the yellow fever vaccine — and the consequences of this scarcity could be devastating. … At the Bill & Melinda Gates Foundation, we view supporting [the four] proven manufacturers as the world’s surest shot at increasing supply — and preventing a widespread yellow fever outbreak. … We know from other disease pandemics that our best defense against a nimble virus is a vaccine that works. With an effective yellow fever vaccine in hand, we’re already at an advantage. By supporting vaccine manufacturers to continue to improve their vaccine production and meet demand, we’re even stronger…” (10/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.